Taro Provides Results for September 30, 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. META
3. SPY
4. MSFT
5. JNJ
6. PLTR
7. LDOS
8. AXP
9. TMUS
10. AON

Go back to Taro Provides Results for September 30, 2018

Taro Pharma (TARO) Misses Q2 EPS by 36c, Approves Special Dividend

November 5, 2018 4:09 PM EST

Taro Pharma (NYSE: TARO) reported Q2 EPS of $1.60, $0.36 worse than the analyst estimate of $1.96. Revenue for the quarter came in at $159 million versus the consensus estimate of $167.41 million.

Special Dividend Approved by Board of Directors

The Taro Board of Directors has declared a $500 million (or... More